NextCure
NXTC
NXTC
59 hedge funds and large institutions have $62.6M invested in NextCure in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 22 increasing their positions, 16 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
27% less capital invested
Capital invested by funds: $86.2M → $62.6M (-$23.6M)
80% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 15
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
59
Holding in Top 10
–
Calls
$246K
Puts
$258K
Top Buyers
| 1 | +$720K | |
| 2 | +$608K | |
| 3 | +$243K | |
| 4 |
Goldman Sachs
New York
|
+$194K |
| 5 |
Renaissance Technologies
New York
|
+$190K |
Top Sellers
| 1 | -$2.89M | |
| 2 | -$2.44M | |
| 3 | -$1.11M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$755K |
| 5 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$692K |